EUVIMEDEUVIMED entdecken
Open Access

Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking

Caitlin C Jokipii Krueger, Guru Madugundu, Amanda Degner, Yesha Patel, Daniel O Stram, Timothy R Church, Natalia Tretyakova

Mutagenesis · 13.02.2020 · 35 (1) · 19-26

DOI: 10.1093/mutage/gez030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mutagenesis, online erschienen am 07.11.2019. Verfasst von Caitlin C Jokipii Krueger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Masonic Cancer Center, University of Minnesota, Minneapolis, MN. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1,3-Butadiene (BD) is a known human carcinogen found in cigarette smoke, automobile exhaust, and urban air. Workers occupationally exposed to BD in the workplace have an increased incidence of leukemia and lymphoma. BD undergoes cytochrome P450-mediated metabolic activation to 3,4-epoxy-1-butene (EB), 1,2,3,4-diepoxybutane (DEB) and 1,2-dihydroxy-3,4-epoxybutane (EBD), which form covalent adducts with DNA. We have previously reported a quantitative nanoLC/ESI+-HRMS3 method for urinary N7-(1-hydroxy-3-buten-2-yl) guanine (EB-GII) adducts as a mechanism-based biomarker of BD exposure. In the present study, the method was updated to include high throughput 96-well solid phase extraction (SPE) and employed to establish urinary EB-GII biomarker stability and association with smoking. Urinary EB-GII levels were measured bimonthly for 1 year in 19 smokers to determine whether single adduct measurement provides reliable levels of EB-GII in an individual smoker. In addition, association of EB-GII with smoking was studied in 17 individuals participating in a smoking cessation program. EB-GII levels decreased 34% upon smoking cessation, indicating that it is associated with smoking status, but may also originate from sources other than exposure to cigarette smoke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedBiomarkers, TumorButadienesCarcinogensChromatography, High Pressure LiquidDNA AdductsFemaleGuanineHumansMaleMiddle AgedSmokingSmoking PreventionSolid Phase ExtractionSpectrometry, Mass, Electrospray Ionization

Substanzen

Biomarkers, TumorButadienesCarcinogensDNA AdductsN-7-(1-hydroxy-3-buten-2-yl)guanineGuanine1,3-butadiene

Autor:innen und Institutionen

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN.
  • Department of Preventative Medicine, School of Medicine, University of Southern California, Los Angeles, CA.
  • Division of Environmental Health Sciences, University of Minnesota School of Public Health, Minneapolis, MN.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Jokipii Krueger, C. C., Madugundu, G., Degner, A., Patel, Y., Stram, D. O., Church, T. R., & Tretyakova, N. (2020). Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking. Mutagenesis, 35(1), 19-26. https://doi.org/10.1093/mutage/gez030

Vancouver

Jokipii Krueger CC, Madugundu G, Degner A, Patel Y, Stram DO, Church TR, et al. Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking. Mutagenesis. 2020;35(1):19-26. doi:10.1093/mutage/gez030

BibTeX
@article{JokipiiKrueger2020,
  author = {Jokipii Krueger, Caitlin C and Madugundu, Guru and Degner, Amanda and Patel, Yesha and Stram, Daniel O and Church, Timothy R and Tretyakova, Natalia},
  title = {Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking},
  journal = {Mutagenesis},
  year = {2020},
  volume = {35},
  number = {1},
  pages = {19--26},
  doi = {10.1093/mutage/gez030}
}
Kostenlos starten →